Nokia Edges Up on Patent Win, Revamp; Thesis Unchanged

What happened

Nokia shares ticked higher in pre-market trading following a UK patent-licensing court victory and a management reshuffle, but these events do not alter the fundamental investment thesis. The DeepValue report maintains a 'WAIT' rating, noting that at $10.30, the stock prices in AI-driven networking upside despite AI-RAN monetization being back-end loaded to Q4 2026 field trials and end-2027 commercialization. The patent win is a modest positive for licensing revenue visibility, but management changes are unlikely to accelerate the timeline for converting AI-RAN pilots into paid deployments. The key risk remains that AI-RAN remains a 'perma-pilot' and optical/IP order intake slows, leaving valuation unsupported at 53.7x P/E. Confirmation must come from measurable order intake and backlog attribution, not press releases or court rulings.

Implication

The patent win and management revamp are positive headlines but do not address the core thesis risk: AI-RAN commercialization timing and the need for sustained optical/IP orders to justify the current rich valuation (53.7x P/E). Investors should remain on the sidelines, using the 90-day checkpoint to require concrete AI-RAN milestone disclosures from Nokia (e.g., named operator field trial start dates). A breach of the $8.50 attractive entry point or a clear disclosure of AI-RAN backlog above €200M would warrant re-evaluation. Until then, the stock offers limited margin of safety with a base case of $11 and bear case of $7.

Thesis delta

No material shift. The patent victory and management changes are incremental positives but do not alter the core thesis: Nokia remains a 'Wait' until AI-RAN order intake or repeat optical/IP awards provide evidence of durable demand. The valuation at ~53x P/E still embeds significant optionality that must be backed by measurable commercial traction, not legal wins or leadership changes.